Cantor Fitzgerald analyst Prakhar Agrawal initiated coverage of Veradermics (MANE) with an Overweight rating.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MANE:
- Opening Day: SpyGlass Pharma soars in debut after strongly priced IPO
- Veradermics completes enrollment in Phase 3 trial of VDPHL01
- Veradermics Completes IPO and Adopts New Governance Structure
- Veradermics opens at $34, IPO priced at $17 per share
- Veradermics indicated to open at $32-$34, IPO priced at $17